Skip to main content
SpringerLink
Log in

Neuroprotection in Miscellaneous Neurological Disorders

  • Protocol
  • First Online:
The Handbook of Neuroprotection

Part of the book series: Springer Protocols Handbooks ((SPH))

Abstract

Several neurological disorders that are not covered in the preceding chapters result in damage to the brain requiring neuroprotection. In addition to this several systemic disorders have neurological manifestations due to damage to the nervous system. Nuroprotective strategies for these disorders are also described in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abou-Donia MB, Siracuse B, Gupta N, Sobel Sokol A. Sarin (GB, O-isopropyl methylphosphonofluoridate) neurotoxicity: critical review. Crit Rev Toxicol 2016;46:845-75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Agrawal L, Louboutin JP, Strayer DS. Preventing HIV-1 Tat-induced neuronal apoptosis using antioxidant enzymes: mechanistic and therapeutic implications. Virology 2007;363:462-72.

    Article  CAS  PubMed  Google Scholar 

  • Alonso-Alconada D, Alvarez A, Arteaga O, et al. Neuroprotective effect of melatonin: a novel therapy against perinatal hypoxia-ischemia. Int J Mol Sci 2013;14:9379-95.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Apoorv TS, Babu PP. Minocycline prevents cerebral malaria, confers neuroprotection and increases survivability of mice during Plasmodium berghei ANKA infection. Cytokine 2017;90:113-123.

    Article  CAS  PubMed  Google Scholar 

  • Arango-Lievano M, Lambert M, Bath KG, et al. Neurotrophic-priming of glucocorticoid receptor signaling is essential for neuronal plasticity to stress and antidepressant treatment. Proc Natl Acad Sci U S A 2015;112:15737-42.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Arranz AM, Perkins KL, Irie F, et al. Hyaluronan deficiency due to Has3 knock-out causes altered neuronal activity and seizures via reduction in brain extracellular space. J Neurosci 2014; 34: 6164-76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Arrich J, Holzer M, Havel C, et al. Pre-hospital versus in-hospital initiation of cooling for survival and neuroprotection after out-of-hospital cardiac arrest. Cochrane Database Syst Rev 2016;3:CD010570.

    PubMed  Google Scholar 

  • Atamna H, Nguyen A, Schultz C, et al. Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways. FASEB J 2008;22:703-12.

    Article  CAS  PubMed  Google Scholar 

  • Atkins HL, Bowman M, Allan D, et al. Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial. Lancet 2016;388:576-85.

    Article  PubMed  Google Scholar 

  • Axelson HW, Oberg G, Askmark H. Successful repeated treatment with high dose cyclophosphamide and autologous blood stem cell transplantation in CIDP. J Neurol Neurosurg Psychiatry 2008;79:612-4.

    Article  CAS  Google Scholar 

  • Azzopardi DV, Strohm B, Edwards AD, et al. Moderate Hypothermia to Treat Perinatal Asphyxial Encephalopathy. N Engl J Med 2009 361: 1349-58.

    Article  CAS  PubMed  Google Scholar 

  • Bachewal P, Gundu C, Yerra VG, et al. Morin exerts neuroprotection via attenuation of ROS induced oxidative damage and neuroinflammation in experimental diabetic neuropathy. Biofactors 2018;44:109-122.

    Article  CAS  PubMed  Google Scholar 

  • Bai L, Lennon DP, Caplan AI, et al. Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat Neurosci 2012;15:862-70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Baker D, Marta M, Pryce G, et al. Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis. EBioMedicine 2017;16:41-50.

    Article  PubMed  PubMed Central  Google Scholar 

  • Barkhof F, de Jong R, Sfikas N, et al. The influence of patient demographics, disease characteristics and treatment on brain volume loss in Trial Assessing Injectable Interferon vs FTY720 Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS), a phase 3 study of fingolimod in multiple sclerosis. Mult Scler 2014;20:1704-13.

    Article  CAS  PubMed  Google Scholar 

  • Barkhof F, Hulst HE, Drulovic J, et al. Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant? Neurology 2010;74:1033-40.

    Article  CAS  PubMed  Google Scholar 

  • Barzegar-Fallah A, Alimoradi H, Mehrzadi S, et al. The neuroprotective effect of tropisetron on vincristine-induced neurotoxicity. Neurotoxicology 2014;41:1-8.

    Article  CAS  PubMed  Google Scholar 

  • Bekenstein U, Mishra N, Milikovsky DZ, et al. Dynamic changes in murine forebrain miR-211 expression associate with cholinergic imbalances and epileptiform activity. Proc Natl Acad Sci U S A 2017;114:E4996-E5005.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bever CT, Judge SI. Sustained-release fampridine for multiple sclerosis. Expert Opin Investig Drugs 2009;18:1013-24.

    Article  CAS  PubMed  Google Scholar 

  • Bloss EB, Hunter RG, Waters EM, et al. Behavioral and biological effects of chronic S18986, a positive AMPA receptor modulator, during aging. Exp Neurol 2008;210:109-17.

    Article  CAS  PubMed  Google Scholar 

  • Bobkova NV, Evgen’ev M, Garbuz DG, et al. Exogenous Hsp70 delays senescence and improves cognitive function in aging mice. Proc Natl Acad Sci U S A 2015;112:16006-11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Boyke J, Driemeyer J, Gaser C, Büchel C, May A. Training-induced brain structure changes in the elderly. J Neurosci 2008;28:7031-5.

    Article  CAS  PubMed  Google Scholar 

  • Brandt-Wouters E, Gerlach OH, Hupperts RM. The effect of postpartum intravenous immunoglobulins on the relapse rate among patients with multiple sclerosis. Int J Gynaecol Obstet 2016;134:194-6.

    Article  CAS  PubMed  Google Scholar 

  • Broad KD, Keverne KB. Placental protection of the fetal brain during short-term food deprivation. Proc Natl Acad Sci U S A 2011;108:15237-41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brock PR, Maibach R, Childs M, et al. Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss. N Engl J Med 2018; 378:2376-85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bui AD, Nguyen TM, Limouse C, et al. Dentate gyrus mossy cells control spontaneous convulsive seizures and spatial memory. Science 2018;359:787-90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Burt RK, Loh Y, Cohen B, et al. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study. Lancet Neurol 2009;8:244-53.

    Article  CAS  PubMed  Google Scholar 

  • Caprariello AV, Rogers JA, Morgan ML, et al. Biochemically altered myelin triggers autoimmune demyelination. Proc Natl Acad Sci U S A 2018;115:5528-5533.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Carbajal KS, Schaumburg C, Strieter R, et al. Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis. PNAS 2010;107:11068-73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Casals-Pascual C, Idro R, Gicheru N, et al. High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria. PNAS 2008;105:2634-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chan D, Binks S, Nicholas JM, et al. Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial. Lancet Neurol 2017;16:591-600.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chao LL, Abadjian L, Hlavin J, et al. Effects of low-level sarin and cyclosarin exposure and Gulf War Illness on brain structure and function: a study at 4T. Neurotoxicology 2011;32:814-22.

    Article  CAS  PubMed  Google Scholar 

  • Chen B, Li J, Borgens R, et al. Neuroprotection by chitosan nanoparticles in oxidative stress-mediated injury. BMC Res Notes 2018;11:49.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Chen LY, Rex CS, Sanaiha Y, et al. Learning induces neurotrophin signaling at hippocampal synapses. Proc Natl Acad Sci U S A 2010;107:7030-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Choi JW, Gardell SE, Herr DR, et al. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. PNAS 2011;108:751-6.

    Article  CAS  PubMed  Google Scholar 

  • Choi YH, Miller JM, Tucker KL, et al. Antioxidant vitamins and magnesium and the risk of hearing loss in the US general population. Am J Clin Nutr 2014;99:148-55.

    Article  CAS  PubMed  Google Scholar 

  • Cohen JA, Barkhof F, Comi G, for the TRANSFORMS Study Group. Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis. NEJM 2010;362:402-15.

    Google Scholar 

  • Comi G, Pulizzi A, Rovaris M, et al. Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet 2008;371:2085-92.

    Article  CAS  PubMed  Google Scholar 

  • Crowther CA, Middleton PF, Voysey M, et al. Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis. PLoS Med 2017;14(10): e1002398.

    Article  PubMed  PubMed Central  Google Scholar 

  • Dallari S, Franciotta D, Carluccio S, et al. Upregulation of integrin expression on monocytes in multiple sclerosis patients treated with natalizumab. J Neuroimmunol 2015;287:76-9.

    Article  CAS  PubMed  Google Scholar 

  • De Benedetti F, Gattorno M, Anton J, et al. Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes. N Engl J Med 2018; 378:1908-19.

    Article  PubMed  Google Scholar 

  • DeBoy CA, Rus H, Tegla C, et al. FLT-3 expression and function on microglia in multiple sclerosis. Exp Mol Pathol 2010;89:109-16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Del Bigio MR, Di Curzio DL. Nonsurgical therapy for hydrocephalus: a comprehensive and critical review. Fluids Barriers CNS 2016;13:3.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Dell’anna AM, Scolletta S, Donadello K, Taccone FS. Early neuroprotection after cardiac arrest. Curr Opin Crit Care 2014;20:250-8.

    Article  PubMed  Google Scholar 

  • Dezfulian C, Kenny E, Lamade A, et al. Mechanistic characterization of nitrite-mediated neuroprotection after experimental cardiac arrest. J Neurochem 2016;139:419-31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dietrich P, Shanmugasundaram R, Shuyu E, Dragatsis I. Congenital hydrocephalus associated with abnormal subcommissural organ in mice lacking huntingtin in Wnt1 cell lineages. Hum Mol Genet 2009;18:142-50.

    Article  CAS  PubMed  Google Scholar 

  • Duplessis CA, Fothergill D. Investigating the potential of statin medications as a nitric oxide (NO) release agent to decrease decompression sickness: a review article. Med Hypotheses 2008;70:560-6.

    Article  CAS  PubMed  Google Scholar 

  • Echouffo-Tcheugui JB, Conner SC, Himali JJ, et al. Circulating cortisol and cognitive and structural brain measures: The Framingham Heart Study. Neurology 2018;91:e1961-e1970.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Elfar JC, Jacobson JA, Puzas JE, et al. Erythropoietin accelerates functional recovery after peripheral nerve injury. J Bone Joint Surg Am 2008;90:1644-53.

    Article  PubMed  PubMed Central  Google Scholar 

  • Farez MF, Mascanfroni ID, Méndez-Huergo SP, et al. Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses. Cell 2015;162:1338-52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fauchère JC, Dame C, Vonthein R, et al. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants. Pediatrics 2008;122:375-82.

    Article  PubMed  Google Scholar 

  • Feng Z, Liu J, Ju R, et al. Hyperbaric oxygen treatment promotes neural stem cell proliferation in the subventricular zone of neonatal rats with hypoxic-ischemic brain damage. Neural Regeneration Research 2013;8:1220-7.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Fledrich R, Rasch L, Abdelaal T, et al. Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy. Nat Commun 2018;9:3025.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fox RJ, Coffey CS, Conwit R, et al. Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis. N Engl J Med 2018; 379:846-855.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fox RJ, Kita M, Cohan SL, et al. BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safety. Curr Med Res Opin 2014;30:251-62.

    Article  CAS  PubMed  Google Scholar 

  • Garcia CAB, Catalão CHR, Machado HR, et al. Edaravone reduces astrogliosis and apoptosis in young rats with kaolin-induced hydrocephalus. Childs Nerv Syst 2017;33:419-428.

    Article  PubMed  Google Scholar 

  • Geffin R, Martinez R, de Las Pozas A, Issac B, McCarthy M. Fingolimod induces neuronal-specific gene expression with potential neuroprotective outcomes in maturing neuronal progenitor cells exposed to HIV. J Neurovirol 2017;23:808-824.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Giovannoni G, Comi G, Cook S, et al, for the CLARITY Study Group. A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis. NEJM 2010;362:416-26.

    Article  CAS  PubMed  Google Scholar 

  • Goodman AD, Brown TR, Krupp LB, et al. Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Lancet 2009;373:732-8.

    Article  CAS  PubMed  Google Scholar 

  • Gopinath B, Flood VM, Rochtchina E, et al. Consumption of omega-3 fatty acids and fish and risk of age-related hearing loss. Am J Clin Nutr 2010;92:416-21.

    Article  CAS  PubMed  Google Scholar 

  • Guenther U, Varelmann D, Putensen C, Wrigge H. Extended therapeutic hypothermia for several days during extracorporeal membrane-oxygenation after drowning and cardiac arrest: two cases of survival with no neurological sequelae. Resuscitation 2009;80:379-81.

    Article  PubMed  Google Scholar 

  • Hafler DA, Compston A, Sawcer S, et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007;357:851-62.

    Article  CAS  PubMed  Google Scholar 

  • Hamana A, Takahashi Y, Tanioka A, et al. Safe and effective interferon-beta gene therapy for the treatment of multiple sclerosis by regulating biological activity through the design of interferon-beta-galectin-9 fusion proteins. Int J Pharm 2018;536:310-317.

    Article  CAS  PubMed  Google Scholar 

  • Hamer M, Sharma N, Batty GD. Association of objectively measured physical activity with brain structure: UK Biobank study. J Intern Med 2018;284:439-443.

    Article  CAS  PubMed  Google Scholar 

  • Hauser SL, Bar-Or A, Comi G, et al. Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis. N Engl J Med 2017;376:221-234.

    Article  CAS  PubMed  Google Scholar 

  • Heinrich UR, Fischer I, Brieger J, et al. Ascorbic acid reduces noise-induced nitric oxide production in the guinea pig ear. Laryngoscope 2008;118:837-42.

    Article  CAS  PubMed  Google Scholar 

  • Hernández C, Simó R. Neuroprotection in diabetic retinopathy. Curr Diab Rep 2012;12:329-37.

    Article  PubMed  CAS  Google Scholar 

  • Ho YJ, Weng JC, Lin CL, et al. Ceftriaxone Treatment for Neuronal Deficits: A Histological and MEMRI Study in a Rat Model of Dementia with Lewy Bodies. Behav Neurol 2018;2018:4618716.

    Article  PubMed  PubMed Central  Google Scholar 

  • Holm H, Nägg K, Ricci F, et al. Biomarkers of microvascular endothelial dysfunction predict incident dementia: a population-based prospective study. J Int Med 2017;282:94-101.

    Article  CAS  Google Scholar 

  • Huang ZL, Pandya D, Banta DK, et al. Cyclophilin inhibitor NIM811 ameliorates experimental allergic encephalomyelitis. J Neuroimmunol 2017;311:40-48.

    Article  CAS  PubMed  Google Scholar 

  • Hughes RA, Donofrio P, Bril V, et al. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Lancet Neurol 2008;7:136-44.

    Article  CAS  PubMed  Google Scholar 

  • Iaffaldano P, Ribatti D, Trojano M. Natalizumab reduces serum pro-angiogenic activity in MS patients. Neurol Sci 2018;39:725-731.

    Article  PubMed  Google Scholar 

  • Ieraci A, Herrera DG. Nicotinamide Protects against Ethanol-Induced Apoptotic Neurodegeneration in the Developing Mouse Brain. PLoS Medicine 2006;3:e101.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Jain KK. Carbon monoxide poisoning. Green, St. Louis (MO), 1990.

    Google Scholar 

  • Jain KK. Textbook of Hyperbaric Medicine, 6th ed. Springer, New York 2017.

    Google Scholar 

  • Jain KK. Cell Therapy. Jain PharmaBiotech Publications, Basel, Switzerland, 2019g.

    Google Scholar 

  • Jain KK. Dalframpidine. In, Roos RP (ed) MedLink Neurology. Medlink Publishing Corporation, San Diego, California, 2019b.

    Google Scholar 

  • Jain KK. Drug-induced Neurological Disorders. 3rd edition, Hogrefe, Göttingen, 2012.

    Google Scholar 

  • Jain KK. Fever: neurologic causes and complications. In, Roos RP (ed) MedLink Neurology. Medlink Publishing Corporation, San Diego, California, 2019h.

    Google Scholar 

  • Jain KK. Fingolimod. In, Roos RP (ed) MedLink Neurology. Medlink Publishing Corporation, San Diego, California, 2019c.

    Google Scholar 

  • Jain KK. Hepatic encephalopathy. In, Roos RP (ed) MedLink Neurology. Medlink Publishing Corporation, San Diego, California, 2019f.

    Google Scholar 

  • Jain KK. Mitoxantrone. In, Roos RP (ed) MedLink Neurology. Medlink Publishing Corporation, San Diego, California, 2019a.

    Google Scholar 

  • Jain KK. Natalizumab. In, Roos RP (ed) MedLink Neurology. Medlink Publishing Corporation, San Diego, California, 2019d.

    Google Scholar 

  • Jain KK. Neurologic aspects of carbon monoxide poisoning. In, Roos RP (ed) MedLink Neurology. Medlink Publishing Corporation, San Diego, California, 2019i.

    Google Scholar 

  • Jain KK. Neurologic disorders of aging. In, Roos RP (ed) MedLink Neurology. Medlink Publishing Corporation, San Diego, California, 2019.

    Google Scholar 

  • Jain KK. Neurological complications of decompression sickness. In Roos RP (ed) MedLink Neurology. Medlink Publishing Corporation, San Diego, California, 2019e.

    Google Scholar 

  • Jain KK. Peripheral neuropathies: treatment with neurotrophic factors. In, Roos RP (ed) MedLink Neurology. Medlink Publishing Corporation, San Diego, California, 2019j.

    Google Scholar 

  • James PB, Jain KK. Decompression sickness. In, Jain KK. Textbook of Hyperbaric Medicine. 6th edition, Springer, 2017.

    Google Scholar 

  • Janelsins MC, Roscoe JA, Berg MJ, et al. IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL/6 mice. Cancer Invest 2010;28:544-53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jellinger KA, Lantos PL. Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update. Acta Neuropathol 2010;119:657-67.

    Article  CAS  PubMed  Google Scholar 

  • Jeong JO, Kim MO, Kim H, et al. Dual Angiogenic and Neurotrophic Effects of Bone Marrow-Derived Endothelial Progenitor Cells on Diabetic Neuropathy. Circulation 2009;119:699-708.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kalinin S, Polak PE, Lin SX, et al. Dimethyl fumarate regulates histone deacetylase expression in astrocytes. J Neuroimmunol 2013;263:13-9.

    Article  CAS  PubMed  Google Scholar 

  • Kamiya K, Fujinami Y, Hoya N, et al. Mesenchymal stem cell transplantation accelerates hearing recovery through the repair of injured cochlear fibrocytes. Am J Pathol 2007;171: 214-26.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kapoor R, Furby J, Hayton T, et al. Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Neurol 2010;9:681-8.

    Article  CAS  PubMed  Google Scholar 

  • Kappos L, Antel J, Comi G, et al. Oral fingolimod (FTY720) for relapsing multiple sclerosis. N Engl J Med 2006;355:1124-40.

    Article  CAS  PubMed  Google Scholar 

  • Kappos L, Radue EW, O’Connor P, et al, for the FREEDOMS Study Group. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. NEJM 2010;362:387-401.

    Google Scholar 

  • Kappos L, Wiendl H, Selmaj K, et al. Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis. N Engl J Med 2015;373:1418-28.

    Article  CAS  PubMed  Google Scholar 

  • Kaster MP, Machado NJ, Silva HB, et al. Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress. Proc Natl Acad Sci U S A 2015;112:7833-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kaur G, Trowsdale J, Fugger L. Natural killer cells and their receptors in multiple sclerosis. Brain 2013;136(Pt 9):2657-76.

    Article  PubMed  Google Scholar 

  • Keeler GD, Kumar S, Palaschak B, et al. Gene Therapy-Induced Antigen-Specific Tregs Inhibit Neuro-inflammation and Reverse Disease in a Mouse Model of Multiple Sclerosis. Mol Ther 2018;26:173-183.

    Article  CAS  PubMed  Google Scholar 

  • Kessler JA, Smith AG, Cha BS, et al. Double-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathy. Ann Clin Transl Neurol 2015;2:465-78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Koivisto A, Alafuzoff I, Savolainen S, et al. Poor Cognitive Outcome in Shunt-Responsive Idiopathic Normal Pressure Hydrocephalus. Neurosurgery 2013;72:1-8.

    Article  PubMed  Google Scholar 

  • Korabecny J, Soukup O, Dolezal R, et al. From pyridinium-based to centrally active acetylcholinesterase reactivators. Mini Rev Med Chem 2014;14:215-21.

    Article  CAS  PubMed  Google Scholar 

  • Kuppermann N, Ghetti S, Schunk JE, et al. Clinical trial of fluid infusion rates for pediatric diabetic ketoacidosis. N Engl J Med 2018;378:2275-87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lanz TV, Becker S, Osswald M, et al. Protein kinase Cβ as a therapeutic target stabilizing blood–brain barrier disruption in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2013;110:14735-40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lazar S, Egoz I, Brandeis R, Chapman S, Bloch-Shilderman E, Grauer E. Propagation of damage in the rat brain following sarin exposure: differential progression of early processes. Toxicol Appl Pharmacol 2016;310:87-97.

    Article  CAS  PubMed  Google Scholar 

  • Lee DH, Rötger C, Appeldoorn CC, et al. Glutathione PEGylated liposomal methylprednisolone (2B3-201) attenuates CNS inflammation and degeneration in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis. J Neuroimmunol 2014;274:96-101.

    Article  CAS  PubMed  Google Scholar 

  • Legriel S, Lemiale V, Schenck M, et al. Hypothermia for Neuroprotection in Convulsive Status Epilepticus. N Engl J Med 2016; 375:2457-67.

    Article  PubMed  Google Scholar 

  • Leon J, Moreno AJ, Garay BI, et al. Peripheral elevation of a Klotho fragment enhances brain function and resilience in young, aging, and a-synuclein transgenic mice. Cell Rep 2017;20:1360-71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lepeta K, Lourenco MV, Schweitzer BC, et al. Synaptopathies: synaptic dysfunction in neurological disorders. J Neurochem 2016;138:785-805.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li R, Rezk A, Miyazaki Y, et al. Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy. Science Translational Medicine 2015;7:310ra166.

    Article  PubMed  CAS  Google Scholar 

  • Liao AC, Craver BM, Tseng BP, et al. Mitochondrial-targeted human catalase affords neuroprotection from proton irradiation. Radiat Res 2013;180:1-6.

    Article  CAS  PubMed  Google Scholar 

  • Lin CH, Sheu WH. Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7-year follow-up subjects. J Int Med 2013;273:102-10.

    Article  Google Scholar 

  • Liu CY, Zhu J, Zheng XY, et al. Anti-N-Methyl-D-aspartate Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis. Mediators Inflamm 2017;2017:6361479.

    PubMed  Google Scholar 

  • Liu-Ambrose T, Eng JJ, Boyd LA, et al. Promotion of the Mind Through Exercise (PROMoTE): A Proof-of-Concept Randomized Controlled Trial of Aerobic Exercise Training in Older Adults with Vascular Cognitive Impairment. BMC Neurology 2010;10:14.

    Article  PubMed  PubMed Central  Google Scholar 

  • Lu T, Aron L, Zullo J, et al. REST and stress resistance in ageing and Alzheimer’s disease. Nature 2014;507:448-54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lundgaard I, Wang W, Eberhardt A, et al. Beneficial effects of low alcohol exposure, but adverse effects of high alcohol intake on glymphatic function. Sci Rep 2018;8:2246.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Luo J, Bavencoffe A, Yang P, et al. Zinc inhibits TRPV1 to alleviate chemotherapy-induced neuropathic pain. J Neurosci 2018;38:474-83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Luo J. Lithium-mediated protection against ethanol neurotoxicity. Front Neurosci 2010;4:41.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Lutterotti A, Yousef S, Sputtek A, et al. Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis. Sci Transl Med 2013;5:188ra75

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Mancardi G, Saccardi R. Autologous haematopoietic stem-cell transplantation in multiple sclerosis. Lancet Neurol 2008;7:626-36.

    Article  PubMed  Google Scholar 

  • Mansilla A, Chaves-Sanjuan A, Campillo NE, et al. Interference of the complex between NCS-1 and Ric8a with phenothiazines regulates synaptic function and is an approach for fragile X syndrome. Proc Natl Acad Sci U S A 2017;114:E999-E1008.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Martina BEE, Smreczak M, Orlowska A, et al. Combination drug treatment prolongs survival of experimentally infected mice with silver-haired bat rabies virus. Vaccine 2018 May 26; pii: S0264-410X(18)30705-9.

    Google Scholar 

  • Masino SA, Li T, Theofilas P, et al. A ketogenic diet suppresses seizures in mice through adenosine A1 receptors. J Clin Invest 2011;121:2679-83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mattoscio M, Nicholas R, Sormani MP, et al. Hematopoietic mobilization: potential biomarker of response to natalizumab in multiple sclerosis. Neurology 2015;84:1473-82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mercey G, Verdelet T, Renou J, et al. Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents. Acc Chem Res 2012;45:756-66.

    Article  CAS  PubMed  Google Scholar 

  • Metz LM, Li DKB, Traboulsee AL, et al. Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis. N Engl J Med 2017;376:2122-33.

    Article  CAS  PubMed  Google Scholar 

  • Milena Z. Adzemovic, Manuel Zeitelhofer, Ulf Eriksson, Tomas Olsson, Ingrid Nilsson. Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response. PLoS ONE 2013; 8 (2): e56586

    Article  CAS  Google Scholar 

  • Miller AE. Oral teriflunomide in the treatment of relapsing forms of multiple sclerosis: clinical evidence and long-term experience. Ther Adv Neurol Disord 2017;10:381-396.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Minagar A, Alexander JS, Sahraian MA, Zivadinov R. Alemtuzumab and multiple sclerosis: therapeutic application Expert Opin Biol Ther 2010;10:421-9.

    Google Scholar 

  • Mooney MR, Unger BT, Boland LL, et al. Therapeutic hypothermia after out-of-hospital cardiac arrest: evaluation of a regional system to increase access to cooling. Circulation 2011;124:206-14.

    Article  PubMed  Google Scholar 

  • Muftuoglu M, Olson A, Marin D, et al. Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy. N Engl J Med 2018;379:1443-1451.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division, Board on Health Sciences Policy, Committee on Preventing Dementia and Cognitive Impairment, et al. Preventing cognitive decline and dementia: a way forward. Washington, DC, National Academies Press, 2017.

    Google Scholar 

  • Nicholas R, Giannetti P, Alsanousi A, et al. Development of oral immunomodulatory agents in the management of multiple sclerosis. Drug Des Devel Ther 2011;5:255-74.

    Article  PubMed  PubMed Central  Google Scholar 

  • Nierenberg NE, Thompson GR, Lewis JS, et al. Voriconazole use and pharmacokinetics in combination with interferon-gamma for refractory cryptococcal meningitis in a patient receiving low-dose ritonavir. Med Mycol 2010;48:532-6.

    Article  CAS  PubMed  Google Scholar 

  • Nishijima K, Ng YS, Zhong L, et al. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol 2007;171:53-67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Norman JP, Perry SW, Reynolds HM, et al. HIV-1 Tat Activates Neuronal Ryanodine Receptors with Rapid Induction of the Unfolded Protein Response and Mitochondrial Hyperpolarization. PLoS ONE 2008;3(11):e3731

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • O’Connor P, Wolinsky JS, Confavreux C, et al. Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis. N Engl J Med 2011;365:1293-03.

    Article  PubMed  Google Scholar 

  • Pachiappan A, Thwin MM, Weng Keong L, et al. ETS2 regulating neurodegenerative signaling pathway of human neuronal (SH-SY5Y) cells exposed to single and repeated low-dose sarin (GB). Chem Res Toxicol 2009;22:990-6.

    Article  CAS  PubMed  Google Scholar 

  • Palanichamy A, Jahn S, Nickles D, et al. Rituximab efficiently depletes increased CD20-expressing T cells in multiple sclerosis patients. J Immunol 2014;193:580-6.

    Article  CAS  PubMed  Google Scholar 

  • Palermo G, Ceravolo R, Bonuccelli U. Advances in the pharmacotherapeutic management of dementia with Lewy bodies. Expert Opin Pharmacother 2018;19:1643-53.

    Article  CAS  PubMed  Google Scholar 

  • Palmer AM. Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis. Curr Opin Invest Drugs 2010; 11:1313-23

    CAS  Google Scholar 

  • Pan HC, Yang DY, Ou YC, et al. Neuroprotective effect of atorvastatin in an experimental model of nerve crush injury. Neurosurgery 2010;67:376-89.

    Article  PubMed  Google Scholar 

  • Papadopoulou A, D’Souza M, Kappos L, Yaldizli O. Dimethyl fumarate for multiple sclerosis. Expert Opin Investig Drugs 2010;19:1603-12.

    Article  CAS  PubMed  Google Scholar 

  • Parihar VK, Limoli CL. Cranial irradiation compromises neuronal architecture in the hippocampus. PNAS 2013;110:12822-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pearce A, Lockwood C, van den Heuvel C, Pearce J. The use of therapeutic magnesium for neuroprotection during global cerebral ischemia associated with cardiac arrest and cardiac surgery in adults: a systematic review. JBI Database System Rev Implement Rep 2017;15:86-118.

    Article  PubMed  Google Scholar 

  • Perwein MK, Smestad JA, Warrington AE, et al. A Comparison of Human Natural Monoclonal Antibodies and Aptamer Conjugates for Promotion of CNS Remyelination: Where Are We Now and What Comes Next? Expert Opin Biol Ther 2018;18:545-560.

    Article  CAS  PubMed  Google Scholar 

  • Pihl-Jensen G, Tsakiri A, Frederiksen JL. Statin treatment in multiple sclerosis: a systematic review and meta-analysis. CNS Drugs 2015;29:277-91.

    Article  CAS  PubMed  Google Scholar 

  • Plavina T, Muralidharan KK, Kuesters G, et al. Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients. Neurology 2017;89:1584-93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Popugaev KA, Savin IA, Goriachev AS, et al. First experience of using CoolGard system in intensive care patients after neurosurgical interventions: series of 10 observations [Article in Russian]. Anesteziol Reanimatol 2011;2:42-9.

    Google Scholar 

  • Pozzilli C, Prosperini L, Borriello G. Treating multiple sclerosis with fingolimod or intramuscular interferon. Expert Opin Pharmacother 2010;11:1957-60.

    Article  CAS  PubMed  Google Scholar 

  • Procaccio V, Bris C, Chao de la Barca JM, et al. Perspectives of drug-based neuroprotection targeting mitochondria. Rev Neurol (Paris) 2014;170:390-400.

    Article  CAS  Google Scholar 

  • Pryce G, Riddall DR, Selwood DL, et al. Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids. J Neuroimmune Pharmacol 2015;10:281-92.

    Article  PubMed  Google Scholar 

  • Rafei M, Hsieh J, Zehntner S, et al. A granulocyte-macrophage colony–stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties. Nat Med 2009;15:1038-45.

    Article  CAS  PubMed  Google Scholar 

  • Rahgozar K, Wright E, Carrithers LM, et al. Mediation of protection and recovery from experimental autoimmune encephalomyelitis by macrophages expressing the human voltage-gated sodium channel NaV1.5. J Neuropathol Exp Neurol 2013;72:489-504.

    Article  CAS  PubMed  Google Scholar 

  • Rice CM, Whone AL, Walsh P, et al. Safety and Feasibility of Autologous Bone Marrow Cellular Therapy in Relapsing-Progressive Multiple Sclerosis. Clin Pharmacol Ther 2010;87:679-85.

    Article  CAS  PubMed  Google Scholar 

  • Rorsman I, Petersen C, Nilsson PC. Cognitive functioning following one-year natalizumab treatment: A non-randomized clinical trial. Acta Neurol Scand 2018;137:117-124.

    Article  CAS  PubMed  Google Scholar 

  • Rothhammer V, Kenison JE, Tjon E, et al. Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation. Proc Natl Acad Sci U S A 2017;114:2012-2017.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rush CA, Atkins HL, Freedman MS. Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Multiple Sclerosis. Cold Spring Harb Perspect Med 2018;pii: a029082

    Google Scholar 

  • Sakowski SA, Heavener SB, Lunn JS, et al. Neuroprotection using gene therapy to induce vascular endothelial growth factor-A expression. Gene Ther 2009;16:1292-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • SalihoÄŸlu M, Ay H, Cincik H, et al. Efficiency of hyperbaric oxygen and steroid therapy in treatment of hearing loss following acoustic trauma. Undersea Hyperb Med 2015;42:539-46.

    PubMed  Google Scholar 

  • Sayouri H, Boudier A, Vigneron C, et al. Hydrogen sulfide: A promising therapy in neuroprotection following cardiac arrest? Ann Pharm Fr 2015;73:401-10.

    Article  CAS  PubMed  Google Scholar 

  • Scannevin RH, Chollate S, Jung MY, et al. Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (erythroid-derived 2)-like 2 pathway. J Pharmacol Exp Ther 2012;341:274-84.

    Article  CAS  PubMed  Google Scholar 

  • Schampel A, Volovitch O, Koeniger T, et al. Nimodipine fosters remyelination in a mouse model of multiple sclerosis and induces microglia-specific apoptosis.Proc Natl Acad Sci U S A 2017 18;114:E3295-E3304

    Article  CAS  Google Scholar 

  • Schattling B, Steinbach K, Thies E, et al. TRPM4 cation channel mediates axonal and neuronal degeneration in experimental autoimmune encephalomyelitis and multiple sclerosis. Nature Medicine 2012;18:1805-11.

    Article  CAS  PubMed  Google Scholar 

  • Schreiber K, Magyari M, Sellebjerg F, et al. High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial. Mult Scler 2017;23:675-685.

    Article  CAS  PubMed  Google Scholar 

  • Schreiner B, Becher B. Perspectives on cytokine-directed therapies in multiple sclerosis, Swiss Med Wkly 2015;145:w14199.

    PubMed  Google Scholar 

  • Schubert D, Currais A, Goldberg J, et al. Geroneuroprotectors: Effective Geroprotectors for the Brain. Trends in Pharmacological Sciences 2018;39:1004-1007.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schwartz BG, Kloner RA, Thomas JL, et al. Therapeutic hypothermia for acute myocardial infarction and cardiac arrest. Am J Cardiol 2012;110:461-6.

    Article  PubMed  Google Scholar 

  • Seidman MD, Tang W, Bai VU, et al. Resveratrol decreases noise-induced cyclooxygenase-2 expression in the rat cochlea. Otolaryngol Head Neck Surg 2013;148:827-33.

    Article  PubMed  Google Scholar 

  • Shan X, Chi L, Ke Y, et al. Manganese superoxide dismutase protects mouse cortical neurons from chronic intermittent hypoxia-mediated oxidative damage. Neurobiol Dis 2007;28:206-15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shankaran S, Pappas A, McDonald SA, et al. Childhood Outcomes after Hypothermia for Neonatal Encephalopathy. N Engl J Med 2012;366:2085-92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shibata SB, Cortez SR, Beyer LA, et al. Transgenic BDNF induces nerve fiber regrowth into the auditory epithelium in deaf cochleae. Exp Neurol 2010;223:464-72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shirani A, Zhao Y, Karim ME, et al. Association between use of interferon Beta and progression of disability in patients with relapsing-remitting multiple sclerosis. JAMA 2012;308:247-56.

    CAS  PubMed  Google Scholar 

  • Sicurelli F, Carluccio MA, Toraldo F, et al. Clinical and biochemical improvement following HSCT in a patient with MNGIE: 1-year follow-up. J Neurol 2012;259:1985-7.

    Article  CAS  PubMed  Google Scholar 

  • Siddarth P, Burggren AC, Eyre HA, et al. Sedentary behavior associated with reduced medial temporal lobe thickness in middle-aged and older adults. PLoS ONE 2018;13: e0195549.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Singhmar P, Huo X, Li Y, et al. Orally active Epac inhibitor reverses mechanical allodynia and loss of intraepidermal nerve fibers in a mouse model of chemotherapy-induced peripheral neuropathy. Pain 2018;159:884-93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Smith CR, Parsons JT, Zhu J, Spiess BD. The effect of intravenous perfluorocarbon emulsions on whole-body oxygenation after severe decompression sickness. Diving Hyperb Med 2012;42:10-7.

    PubMed  Google Scholar 

  • Sperling MA. Fluid Composition, Infusion Rate, and Brain Injury in Diabetic Ketoacidosis. N Engl J Med 2018;378:2336-8.

    Article  PubMed  Google Scholar 

  • Stegbauer J, Lee DH, Seubert S, et al. Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system. PNAS 2009;106:14942-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Talmage GD, Coppes OJM, Javed A, Bernard J. Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: a prospective, non-randomized pilot study. PLoS One 2017;12(4):e0173299.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Terni B, Rey MJ, Boluda S, et al. Mutant ubiquitin and p62 immunoreactivity in cases of combined multiple system atrophy and Alzheimer’s disease. Acta Neuropathol 2007;113:403-16.

    Article  PubMed  Google Scholar 

  • The ACCORD Study Group and ACCORD Eye Study Group. Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes. NEJM 2010;363:233-244.

    Article  CAS  Google Scholar 

  • Theurl M, Lener D, Albrecht-Schgoer K, et aal. Gene therapy with the angiogenic neuropeptide secretoneurin ameliorates experimental diabetic neuropathy. FASEB J 2018;32:4815-4823.

    Article  CAS  PubMed  Google Scholar 

  • Tona Y, Hamaguchi K, Ishikawa M, et al. Therapeutic potential of a gamma-secretase inhibitor for hearing restoration in a guinea pig model with noise-induced hearing loss. BMC Neuroscience 2014;15:66.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Trevino K, McClintock SM, Husain MM. A review of continuation electroconvulsive therapy: application, safety, and efficacy. J ECT 2010;26:186-95.

    Article  PubMed  Google Scholar 

  • Tselis A, Khan OA, Lisak RP. Approaches to neuroprotective strategies in multiple sclerosis. Expert Opin Pharmacother 2010;11: 2869-78.

    Article  PubMed  Google Scholar 

  • Tu S, Akhtar MW, Nakanishi N. NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism. Nature Communications 2017;8:1488

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Upadhya D, Hattiangady B, Castro OW, et al. Human induced pluripotent stem cell-derived MGE cell grafting after status epilepticus attenuates chronic epilepsy and comorbidities via synaptic integration. Proc Natl Acad Sci U S A 2019;116:287-296.

    Article  CAS  PubMed  Google Scholar 

  • Verghese PB, Sasakib Y, Yang D, et al. Nicotinamide mononucleotide adenylyl transferase 1 protects against acute neurodegeneration in developing CNS by inhibiting excitotoxic-necrotic cell death. Proc Natl Acad Sci U S A 2011;108:19054-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Villapol S, Saavedra JM. Neuroprotective effects of angiotensin receptor blockers. Am J Hypertens 2015;28:289-99.

    Article  CAS  PubMed  Google Scholar 

  • Walter EJ, Carraretto M. The neurological and cognitive consequences of hyperthermia. Crit Care 2016;20:199.

    Google Scholar 

  • Wang JT, Medress ZA, Vargas ME, Barre BE. Local axonal protection by WldS as revealed by conditional regulation of protein stability. Proc Natl Acad Sci U S A 2015;112:10093-100.

    Article  CAS  Google Scholar 

  • Warrington JP, Csiszar A, Johnson DA, et al. Cerebral microvascular rarefaction induced by whole brain radiation is reversible by systemic hypoxia in mice. Am J Physiol Heart Circ Physiol 2011;300: H736–744.

    Article  CAS  PubMed  Google Scholar 

  • Warrington JP, Csiszar A, Mitschelen M, et al. Whole brain radiation-induced impairments in learning and memory are time-sensitive and reversible by systemic hypoxia. PLoS ONE 2012;7: e30444.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Watchko JF, Tiribelli C. Bilirubin-induced neurologic damage − mechanisms and management approaches. N Engl J Med 2013;369:2021-30.

    Article  CAS  PubMed  Google Scholar 

  • Waubant E, Pelletier D, Mass M, et al. Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study. Neurology 2012;78:1171-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Weigel KJ, Lynch SG, Levine SM, et al. Iron chelation and multiple sclerosis. ASN Neuro 2014;6:e00136.

    PubMed  PubMed Central  Google Scholar 

  • Wiberg S, Hassager C, Thomsen JH, et al. GLP-1 analogues for neuroprotection after out-of-hospital cardiac arrest: study protocol for a randomized controlled trial. Trials 2016;17:304.

    Google Scholar 

  • Willoughby RE Jr. A cure for a rabies? Sci Am 2007;296:88-95.

    Article  PubMed  Google Scholar 

  • Wilson AD, Hart A, Brännström T, et al. Delayed acetyl-L-carnitine administration and its effect on sensory neuronal rescue after peripheral nerve injury. J Plast Reconstr Aesthet Surg 2007;60:114-8.

    Article  PubMed  Google Scholar 

  • Wilson RS, Leurgans SE, Boyle PA, et al. Neurodegenerative basis of age-related cognitive decline. Neurology 2010;75:1070-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wolfsdorf JI, Glaser N, Agus M, et al. Diabetic ketoacidosis and hyperglycemic hyperosmolar state: a consensus statement from the International Society for Pediatric and Adolescent Diabetes (ISPAD). Pediatr Diabetes 2018;19 Suppl 27:155-177.

    Article  PubMed  Google Scholar 

  • Wu Q, Chen W, Sinha B, et al. Neuroprotective agents for neonatal hypoxic-ischemic brain injury. Drug Discov Today 2015;20:1372-81.

    Article  CAS  PubMed  Google Scholar 

  • Wu YW, Bauer LA, Ballard RA, et al. Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics. Pediatrics 2012;130:683-91.

    Article  PubMed  PubMed Central  Google Scholar 

  • Yadav V, Bourdette DN, Bowen JD, et al. Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study. Autoimmune Dis 2012;2012:954739.

    PubMed  Google Scholar 

  • Yan R, Zhang J, Park HJ, et al. Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson’s disease and DLB. Proc Natl Acad Sci U S A 2018;115:E12053-E12062.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yang D, Nemkul N, Shereen A, et al. Therapeutic administration of plasminogen activator inhibitor-1 prevents hypoxic-ischemic brain injury in newborns. J Neurosci 2009;29:8669-74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zeiler FA, Jackson AC. Critical Appraisal of the Milwaukee Protocol for Rabies: This Failed Approach Should Be Abandoned. Can J Neurol Sci 2016;43:44-51.

    Article  PubMed  Google Scholar 

  • Zhou BY, Lu GJ, Huang YQ, et al. Efficacy of hyperbaric oxygen therapy under different pressures on neonatal hypoxic-ischemic encephalopathy. Zhongguo Dang Dai Er Ke Za Zhi 2008;10:133-5.

    CAS  PubMed  Google Scholar 

  • Zhu Y, Fenik P, Zhan G, et al. Eif-2a protects brainstem motoneurons in a murine model of sleep apnea. J Neurosci 2008;28:2168-78

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zou Y, Corniola R, Leu D, et al. Extracellular superoxide dismutase is important for hippocampal neurogenesis and preservation of cognitive functions after irradiation. PNAS 2012;109:21522-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zuercher P, Springe D, Grandgirard D, et al. A randomized trial of the effects of the noble gases helium and argon on neuroprotection in a rodent cardiac arrest model. BMC Neurol 2016;16:43.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Jain PharmaBiotech, Basel, Switzerland

    Kewal K. Jain

Authors
  1. Kewal K. Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Jain, K.K. (2019). Neuroprotection in Miscellaneous Neurological Disorders. In: The Handbook of Neuroprotection. Springer Protocols Handbooks. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9465-6_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-9465-6_11

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-4939-9464-9

  • Online ISBN: 978-1-4939-9465-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation